Concepedia

Anke van Erp

AV

Statistics

Publications

6

Citations

248

H-Index

6

Active since

2016

Affiliations

Radboud University Nijmegen(Current)

Radboud University Medical Center

Institute of Cancer Research

Royal Marsden NHS Foundation Trust

Dermatopathologie Friedrichshafen

Anke van Erp is an author at Radboud University Nijmegen specializing in molecular oncology, oncology, and malignant neoplasms.

Publications per year

2016–2021

6

Publications

6

Expression and clinical association of programmed cell death-1, programmed death-ligand-1 and CD8+ lymphocytes in primary sarcomas is subtype dependent

Anke van Erp, Yvonne M.H. Versleijen‐Jonkers, Melissa H.S. Hillebrandt-Roeffen et al. · Oncotarget · 2017 · 98 citations · Full text

Life Sciences, Immunology, Oncology +17

Targeting Anaplastic Lymphoma Kinase (ALK) in Rhabdomyosarcoma (RMS) with the Second-Generation ALK Inhibitor Ceritinib

Anke van Erp, Melissa H.S. Hillebrandt-Roeffen, Laurens van Houdt et al. · Targeted Oncology · 2017 · 39 citations · Full text

Medicine, Oncology, Pharmacology +17

Phosphoproteomic Profiling Reveals ALK and MET as Novel Actionable Targets across Synovial Sarcoma Subtypes

Emmy D.G. Fleuren, Myrella Vlenterie, Winette T.A. van der Graaf et al. · Cancer Research · 2017 · 35 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Genetic diversity of lactase persistence in East African populations

Hisham Y. Hassan, Anke van Erp, Martin Jaeger et al. · BMC Research Notes · 2016 · 32 citations · Full text

Life Sciences, Evolutionary Biology, Genetics +15

Olaparib and temozolomide in desmoplastic small round cell tumors: a promising combination in vitro and in vivo

Anke van Erp, Laurens van Houdt, Melissa H.S. Hillebrandt-Roeffen et al. · Journal of Cancer Research and Clinical Oncology · 2020 · 29 citations · Full text

Medicine, Oncology, Pharmacology +15

1–5 of 6